Annual FCF
-$29.21 M
-$5.74 M-24.47%
December 31, 2022
Summary
- As of February 24, 2025, ARDS annual free cash flow is -$29.21 million, with the most recent change of -$5.74 million (-24.47%) on December 31, 2022.
- During the last 3 years, ARDS annual FCF has fallen by -$20.88 million (-250.52%).
- ARDS annual FCF is now -378.37% below its all-time high of -$6.11 million, reached on December 31, 2016.
Performance
ARDS Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$983.00 K
+$3.36 M+77.37%
September 30, 2023
Summary
- As of February 24, 2025, ARDS quarterly free cash flow is -$983.00 thousand, with the most recent change of +$3.36 million (+77.37%) on September 30, 2023.
- Over the past year, ARDS quarterly FCF has increased by +$3.36 million (+77.37%).
- ARDS quarterly FCF is now -125.57% below its all-time high of $3.84 million, reached on September 30, 2019.
Performance
ARDS Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$17.93 M
+$3.28 M+15.47%
September 30, 2023
Summary
- As of February 24, 2025, ARDS TTM free cash flow is -$17.93 million, with the most recent change of +$3.28 million (+15.47%) on September 30, 2023.
- Over the past year, ARDS TTM FCF has increased by +$3.28 million (+15.47%).
- ARDS TTM FCF is now -640.77% below its all-time high of -$2.42 million, reached on June 30, 2020.
Performance
ARDS TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ARDS Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -24.5% | +77.4% | +15.5% |
| 3 y3 years | -250.5% | +82.5% | -51.1% |
| 5 y5 years | -60.0% | -125.6% | -115.2% |
ARDS Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -24.5% | at low | at high | +90.3% | at high | +38.8% |
| 5 y | 5-year | -250.5% | at low | -127.7% | +90.3% | -640.8% | +38.8% |
| alltime | all time | -378.4% | at low | -125.6% | +90.3% | -640.8% | +38.8% |
Aridis Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$983.00 K(-77.4%) | -$17.93 M(-15.5%) |
| Jun 2023 | - | -$4.34 M(+8.5%) | -$21.22 M(-7.9%) |
| Mar 2023 | - | -$4.00 M(-53.5%) | -$23.02 M(-21.2%) |
| Dec 2022 | -$29.21 M(+24.5%) | -$8.61 M(+101.8%) | -$29.21 M(+20.3%) |
| Sep 2022 | - | -$4.26 M(-30.7%) | -$24.29 M(-15.5%) |
| Jun 2022 | - | -$6.15 M(-39.6%) | -$28.73 M(-2.0%) |
| Mar 2022 | - | -$10.19 M(+176.4%) | -$29.31 M(+24.9%) |
| Dec 2021 | -$23.47 M(+12.6%) | -$3.69 M(-57.7%) | -$23.47 M(-6.9%) |
| Sep 2021 | - | -$8.71 M(+29.4%) | -$25.21 M(+14.1%) |
| Jun 2021 | - | -$6.73 M(+55.0%) | -$22.10 M(+7.3%) |
| Mar 2021 | - | -$4.34 M(-20.0%) | -$20.60 M(-1.2%) |
| Dec 2020 | -$20.84 M | -$5.43 M(-3.1%) | -$20.84 M(+75.7%) |
| Sep 2020 | - | -$5.60 M(+7.1%) | -$11.87 M(+390.1%) |
| Jun 2020 | - | -$5.23 M(+14.0%) | -$2.42 M(-51.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$4.59 M(-229.2%) | -$4.99 M(-40.2%) |
| Dec 2019 | -$8.33 M(-66.6%) | $3.55 M(-7.7%) | -$8.33 M(-59.8%) |
| Sep 2019 | - | $3.84 M(-149.3%) | -$20.73 M(-28.6%) |
| Jun 2019 | - | -$7.79 M(-1.8%) | -$29.05 M(+3.1%) |
| Mar 2019 | - | -$7.93 M(-10.4%) | -$28.17 M(+12.9%) |
| Dec 2018 | -$24.95 M(+36.7%) | -$8.85 M(+97.9%) | -$24.95 M(+21.4%) |
| Sep 2018 | - | -$4.47 M(-35.3%) | -$20.55 M(-1.6%) |
| Jun 2018 | - | -$6.92 M(+46.9%) | -$20.88 M(+6.2%) |
| Mar 2018 | - | -$4.71 M(+5.8%) | -$19.66 M(+7.7%) |
| Dec 2017 | -$18.25 M(+199.0%) | -$4.45 M(-7.3%) | -$18.25 M(+32.2%) |
| Sep 2017 | - | -$4.80 M(-15.8%) | -$13.80 M(+53.3%) |
| Jun 2017 | - | -$5.70 M(+72.3%) | -$9.01 M(+172.3%) |
| Mar 2017 | - | -$3.31 M | -$3.31 M |
| Dec 2016 | -$6.11 M | - | - |
FAQ
- What is Aridis Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Aridis Pharmaceuticals?
- What is Aridis Pharmaceuticals annual FCF year-on-year change?
- What is Aridis Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Aridis Pharmaceuticals?
- What is Aridis Pharmaceuticals quarterly FCF year-on-year change?
- What is Aridis Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Aridis Pharmaceuticals?
- What is Aridis Pharmaceuticals TTM FCF year-on-year change?
What is Aridis Pharmaceuticals annual free cash flow?
The current annual FCF of ARDS is -$29.21 M
What is the all time high annual FCF for Aridis Pharmaceuticals?
Aridis Pharmaceuticals all-time high annual free cash flow is -$6.11 M
What is Aridis Pharmaceuticals annual FCF year-on-year change?
Over the past year, ARDS annual free cash flow has changed by -$5.74 M (-24.47%)
What is Aridis Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of ARDS is -$983.00 K
What is the all time high quarterly FCF for Aridis Pharmaceuticals?
Aridis Pharmaceuticals all-time high quarterly free cash flow is $3.84 M
What is Aridis Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, ARDS quarterly free cash flow has changed by +$3.36 M (+77.37%)
What is Aridis Pharmaceuticals TTM free cash flow?
The current TTM FCF of ARDS is -$17.93 M
What is the all time high TTM FCF for Aridis Pharmaceuticals?
Aridis Pharmaceuticals all-time high TTM free cash flow is -$2.42 M
What is Aridis Pharmaceuticals TTM FCF year-on-year change?
Over the past year, ARDS TTM free cash flow has changed by +$3.28 M (+15.47%)